SciELO - Scientific Electronic Library Online

 
vol.11 número1Transición analgésica tras anestesia basada en remifentanilo en cirugía abdominal mayor: morfina-ketorolaco versus analgesia epidural índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista de la Sociedad Española del Dolor

versión impresa ISSN 1134-8046

Resumen

EGOCHEAGA, J.  y  VALLE, M. del. Use of antihomotoxic drug therapy for the management of symptoms associated to fibromyalgia. Rev. Soc. Esp. Dolor [online]. 2004, vol.11, n.1, pp.4-8. ISSN 1134-8046.

Introduction: The fybromyalgia syndrome is a widespread chronic illness whose etiopatogenic is ignored. The patient affections present pains of characteristic muscle-skeletal of systemic localization as well as numerous sensitive localizations or trigger points that usually present concrete situations. It’s associates a psychological clinic determined by depression, general fatigue and dysfunctions of the dream equally. The habitual complementary tests as hemogram, biochemistry, VSG, muscular enzymes, thyroid function, rheumathoid factor and ELL are negative. The habitually used drugs is the amitriptilina, the fluoxetina and the alprazolam, all of them with important secondary effects. Material and methods: This article tries to value the short term effectiveness (8 weeks) of a pharmacological antihomotoxic treatment (Traumeel®, Spascupreel®, Graphites Homaccord®, Cerebrum compositum® and Thalamus compositum®) versus a placebo (physiologic serum) (blind double) in 20 patients diagnosed of fybromyalgia. The analysis of the symptoms was carried out by means of a subjective scale (all the parameters analytic objectives are negative) and numeric that points out the intensity of the same ones. Results: The obtained results show us a significant improvement in the muscular and psychological symptoms with regard to the previous state in the treatment with drugs, not existing significant answer in the treatment with placebo. In relation to the pathology to articulate, significant improvements are not observed neither with drug neither with placebo. We determine an improvement in the quality of life with the proposed substances that was reflected equally in the incorporation of an important number of the treated patients to the habitual work. Conclusions: We consider effective this type of short term treatment in these patients, looking forward to the effectiveness from the same ones to longer term.

Palabras clave : Fybromyalgia syndrome; Antihomotoxic drugs.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons